What is IDEAYA Biosciences, Inc.'s D&A?

IDEAYA Biosciences, Inc. (IDYA) reported D&A of $688K in Q1 2026.

How has IDEAYA Biosciences, Inc.'s D&A changed year-over-year?

IDEAYA Biosciences, Inc.'s D&A increased by 14.7% year-over-year, from $600K to $688K.

What is the long-term trend for IDEAYA Biosciences, Inc.'s D&A?

Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s D&A has grown at a 11.9% compound annual growth rate (CAGR), from $1.73M to $2.7M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

IDEAYA Biosciences, Inc. IDYA D&A

D&A at other companies

Bristol-Myers SquibbBMY

$594M-41.3%

AmgenAMGN

$1.12B-19.5%

Tango TherapeuticsTNGX

$463K-25.6%

Arcus BiosciencesRCUS

$2M-33.3%

Erasca, Inc.ERAS

$723K-12.0%

ImmunomeIMNM

$603K-1.3%

Other financials

Income statement

See full

Revenue$6.6M—

Operating income-$108.5M-28.6%

Net income-$98.5M-36.5%

EPS (diluted)-$1.11-35.4%

Balance sheet

See full

Cash & equivalents$157.5M+21.2%

Total debt$28.6M+10.1%

Total equity$937.3M-8.5%

Total assets$1.0B-6.4%

Cash flow

See full

Operating cash flow-$75.2M-24.6%

CapEx$967.0K-27.3%

Free cash flow-$76.1M-23.5%

Valuation

See full

Market cap$3.36B+104%

Enterprise value$3.23B+110%

P/S14.5×+9.9×

Profitability

See full

Operating margin-4,671.1%-5,434pp

Net margin-3,921.1%-4,562pp

FCF margin-3,592%-4,290pp

Returns & leverage

See full

Return on equity-14.3%-5.0pp

Debt / equity0×0.0×

Current ratio10.7×-3.2×

Where this comes from

Reported directly by IDEAYA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEAYA Biosciences, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s D&A?: IDEAYA Biosciences, Inc. (IDYA) reported D&A of $688K in Q1 2026.
How has IDEAYA Biosciences, Inc.'s D&A changed year-over-year?: IDEAYA Biosciences, Inc.'s D&A increased by 14.7% year-over-year, from $600K to $688K.
What is the long-term trend for IDEAYA Biosciences, Inc.'s D&A?: Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s D&A has grown at a 11.9% compound annual growth rate (CAGR), from $1.73M to $2.7M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.